Assessment of Liver Graft Steatosis: Where Do We Stand?


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
03 2019
Historique:
received: 04 08 2018
accepted: 28 10 2018
pubmed: 1 11 2018
medline: 17 3 2020
entrez: 1 11 2018
Statut: ppublish

Résumé

The growing number of patients on waiting lists for liver transplantation and the shortage of organs have forced many centers to adopt extended criteria for graft selection, moving the limit of acceptance for marginal livers. Steatotic grafts that were, in the past, considered strictly unacceptable for transplantation because of the high risk of early nonfunction are now considered as a potential resource for organ implementation. Several methods to diagnose, measure, classify, and stage steatosis exist, but none can be considered qualitatively and quantitatively "the ideal method" to date. Clinical, biological, and imaging data can be very helpful to estimate graft steatosis, but histology still remains the gold standard. There is an increasing need for rapid and reliable tools to assess graft steatosis. Herein, we present a comprehensive review of the approaches that are currently used to quantify steatosis in liver grafts.

Identifiants

pubmed: 30380197
doi: 10.1002/lt.25379
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

500-509

Informations de copyright

Copyright © 2018 by the American Association for the Study of Liver Diseases.

Auteurs

Manuela Cesaretti (M)

Department of HPB Surgery and Liver Transplantation, Hôpital Beaujon, AP-HP, Clichy, France.
Department of Nanophysics, Italian Institute of Technology, Genova, Italy.

Pietro Addeo (P)

Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre-Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.

Luigi Schiavo (L)

Department of Cardio-Thoracic and Respiratory Science, University of Campania "Luigi Vanvitelli," Naples, Italy.
IX Division of General Surgery, Vascular Surgery and Applied Biotechnology, Naples University Policlinic, Naples, Italy.

Rodolphe Anty (R)

Faculty of Medicine, University of Nice-Sophia Antipolis, Nice, France.
INSERM, U1065, Team 8 "Hepatic complications in obesity," Nice, France.
Centre Hospitalier Universitaire Nice, Digestive Center, Nice, France.

Antonio Iannelli (A)

Faculty of Medicine, University of Nice-Sophia Antipolis, Nice, France.
Digestive Unit, Archet 2 Hospital, University Hospital of Nice, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH